65.3 F
San Diego
Sunday, Feb 25, 2024
-Advertisement-

CoDa Receives Venture Funding

San Diego-based CoDa Therapeutics Inc., which is developing Nexagon, a topical cream to treat wounds, has garnered $10 million in a Series A financing round.

The funding was provided by Domain Associates, a San Diego venture firm that has supported Amylin Pharmaceuticals Inc., Biosite Inc. and NovaCardia.

Bradford Duft, chief executive officer of CoDa, is a patent attorney and was formerly vice president and general counsel at Amylin.

CoDa will use the $10 million for testing Nexagon’s ability to heal skin and eye wounds through phase one and two clinical trials.

CoDa’s technology was discovered by CoDa Therapeutics Ltd., a New Zealand company formed by inventors Dr. Colin Green, of the University of Auckland, and Dr. David Becker, of University College London. Clinical trials are conducted in New Zealand.

, Katie Weeks

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-